Clinical Trial Update: Extensive Stage Sclc Patients Who Were Benefit From First-line Treatment Accept Temozolomide Maintain Therapeutic [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating maintenance temozolomide in extensive-stage small cell lung cancer patients who benefited from first-line treatment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensive-stage Small Cell Lung Cancer

Drugs mentioned

• Temozolomide (Temozolomide)

Snippet

Sponsor: Yunpeng Liu | Conditions: Extensive Stage Small Cell Lung Cancer | Phase 2 | Status: UNKNOWN